Park Medi World Limited (NSE:PARKHOSPS)
India
· Delayed Price · Currency is INR 236.88
+4.18 (1.80%)
At close: Apr 27, 2026
Park Medi World Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 15,729 | 13,936 | 12,311 | 12,546 | 10,844 | 7,659 |
| Revenue Growth (YoY) | - | 13.20% | -1.88% | 15.70% | 41.58% | - |
| Cost of Revenue | 6,158 | 5,842 | 5,045 | 4,273 | 3,115 | 1,383 |
| Gross Profit | 9,571 | 8,094 | 7,266 | 8,273 | 7,729 | 6,276 |
| Selling, General & Admin | 2,640 | 2,277 | 1,649 | 1,445 | 1,274 | 86.71 |
| Other Operating Expenses | 2,815 | 2,044 | 2,509 | 2,917 | 3,014 | 3,085 |
| Operating Expenses | 6,073 | 4,903 | 4,664 | 4,767 | 4,639 | 3,408 |
| Operating Income | 3,499 | 3,190 | 2,602 | 3,506 | 3,090 | 2,868 |
| Interest Expense | -334.77 | -588.5 | -695.32 | -491.95 | -380.35 | -229.32 |
| Interest & Investment Income | 284.99 | 284.99 | 251.01 | 157.02 | 63.32 | 19.25 |
| Other Non Operating Income (Expenses) | -0.86 | -3.51 | 18.06 | -0.03 | -8.11 | -9.52 |
| EBT Excluding Unusual Items | 3,448 | 2,883 | 2,176 | 3,171 | 2,765 | 2,649 |
| Gain (Loss) on Sale of Assets | -19.43 | -19.43 | 14.44 | -5.96 | -2.86 | 0.25 |
| Asset Writedown | - | - | -32.64 | - | - | - |
| Other Unusual Items | 2.74 | 2.74 | 21.81 | -17.77 | 20.4 | -101.86 |
| Pretax Income | 3,431 | 2,867 | 2,182 | 3,150 | 2,784 | 2,547 |
| Income Tax Expense | 711.21 | 734.6 | 661.56 | 868.42 | 789.92 | 678.06 |
| Earnings From Continuing Operations | 2,720 | 2,132 | 1,520 | 2,282 | 1,994 | 1,869 |
| Minority Interest in Earnings | -112.94 | -80.52 | 14.85 | -85.12 | -186.07 | -321.14 |
| Net Income | 2,607 | 2,052 | 1,535 | 2,197 | 1,808 | 1,548 |
| Net Income to Common | 2,607 | 2,052 | 1,535 | 2,197 | 1,808 | 1,548 |
| Net Income Growth | - | 33.66% | -30.13% | 21.52% | 16.78% | - |
| Shares Outstanding (Basic) | 385 | 384 | 384 | 384 | 384 | 384 |
| Shares Outstanding (Diluted) | 385 | 384 | 384 | 384 | 384 | 384 |
| EPS (Basic) | 6.77 | 5.34 | 3.99 | 5.71 | 4.70 | 4.03 |
| EPS (Diluted) | 6.77 | 5.34 | 3.99 | 5.71 | 4.70 | 4.03 |
| EPS Growth | - | 33.66% | -30.13% | 21.52% | 16.78% | - |
| Free Cash Flow | - | 322.37 | 2,900 | 965.96 | 625.8 | 794.9 |
| Free Cash Flow Per Share | - | 0.84 | 7.54 | 2.51 | 1.63 | 2.07 |
| Gross Margin | 60.85% | 58.08% | 59.02% | 65.94% | 71.28% | 81.94% |
| Operating Margin | 22.24% | 22.89% | 21.14% | 27.94% | 28.50% | 37.45% |
| Profit Margin | 16.57% | 14.72% | 12.47% | 17.51% | 16.67% | 20.21% |
| Free Cash Flow Margin | - | 2.31% | 23.55% | 7.70% | 5.77% | 10.38% |
| EBITDA | 4,042 | 3,708 | 3,066 | 3,888 | 3,428 | 3,104 |
| EBITDA Margin | 25.70% | 26.61% | 24.91% | 30.99% | 31.61% | 40.53% |
| D&A For EBITDA | 543.12 | 517.69 | 464.3 | 382.25 | 338.32 | 236.06 |
| EBIT | 3,499 | 3,190 | 2,602 | 3,506 | 3,090 | 2,868 |
| EBIT Margin | 22.24% | 22.89% | 21.14% | 27.94% | 28.50% | 37.45% |
| Effective Tax Rate | 20.73% | 25.62% | 30.32% | 27.57% | 28.38% | 26.62% |
| Revenue as Reported | 16,055 | 14,260 | 12,631 | 12,722 | 10,940 | 7,694 |
| Advertising Expenses | - | 168.72 | 66.41 | 78.9 | 61.11 | 7.83 |
Source: S&P Capital IQ. Standard template. Financial Sources.